Cannabis
Aurora Cannabis Again Scores Highest Among Cannabis Corporate Boards in The Globe and Mail’s Board Games Report
Aurora Cannabis Inc. (the “Company” or “Aurora“) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to acknowledge the Company’s increased ranking in The Globe and Mail’s 2021 annual Report on Business review of Corporate Boards, known as Board Games. As recognized in the 2021 Board Games results, Aurora received 77 out of 100 eligible points, ranking notably higher than others in its peer group of cannabis companies.
For the 20th year in a row, Report on Business has assessed the boards and governance practices of Canada’s largest corporations within the S&P/TSX Composite using a rigorous set of governance criteria designed to go beyond minimum mandatory rules imposed by regulators. Evaluated across four categories including Board Composition, Shareholding and Compensation, Shareholder Rights, and Disclosure, Aurora’s 2021 score signifies a considerable improvement from the previous years’ results of 72 and 67 out of 100 in 2020 and 2019, respectively.
Ronald Funk, Chairman of Aurora stated, “With each passing year, Aurora continues to exhibit growth and maturity across all areas of the business. Our improved ranking in the 2021 Board Games report is a strong indication of the progress we are making as an organization as we continue to identify ways in which our policies and practices can better serve our stakeholders. I am proud and honoured to be part of a Board that stands out from its peers and demonstrates strength in governance, strategic direction and accountability.”
Aurora’s 2021 Proxy Circular can be viewed here. For more information on The Globe and Mail’s Board Games methodology and to view this year’s comprehensive ranking of Canada’s corporate boards, visit here.
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth